Sera Prognostics, Inc.

Nasdaq SERA · Salt Lake City, UT

Works in Renal & urogenital · Women's health

Sera Prognostics, Inc. is a clinical trial sponsor based in Salt Lake City, UT, listed as Nasdaq SERA. It has 1 active clinical trial with 6,500 planned participants, in Renal & urogenital and Women's health. Since 2021 it has completed 1 trial and stopped 0 early.

Trial track record · since 2021

1Active trials6,500 planned participants
1Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq SERA

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 1 active trial

StageTrialStatus

Questions about Sera Prognostics, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-12-06.

Approve Suite is not affiliated with Sera Prognostics, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.